Cargando…

Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events

BACKGROUND: Familial hypercholesterolemia (FH) may arise from deleterious monogenic variants in FH‐causing genes as well as from a polygenic cause. We evaluated the relationships between monogenic FH and polygenic hypercholesterolemia in influencing the long‐term response to therapy and the risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Erasmo, Laura, Minicocci, Ilenia, Di Costanzo, Alessia, Pigna, Giovanni, Commodari, Daniela, Ceci, Fabrizio, Montali, Anna, Brancato, Francesca, Stanca, Ilaria, Nicolucci, Antonio, Ascione, Andrea, Galea, Nicola, Carbone, Iacopo, Francone, Marco, Maranghi, Marianna, Arca, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200757/
https://www.ncbi.nlm.nih.gov/pubmed/33890476
http://dx.doi.org/10.1161/JAHA.120.018932
_version_ 1783707675592228864
author D’Erasmo, Laura
Minicocci, Ilenia
Di Costanzo, Alessia
Pigna, Giovanni
Commodari, Daniela
Ceci, Fabrizio
Montali, Anna
Brancato, Francesca
Stanca, Ilaria
Nicolucci, Antonio
Ascione, Andrea
Galea, Nicola
Carbone, Iacopo
Francone, Marco
Maranghi, Marianna
Arca, Marcello
author_facet D’Erasmo, Laura
Minicocci, Ilenia
Di Costanzo, Alessia
Pigna, Giovanni
Commodari, Daniela
Ceci, Fabrizio
Montali, Anna
Brancato, Francesca
Stanca, Ilaria
Nicolucci, Antonio
Ascione, Andrea
Galea, Nicola
Carbone, Iacopo
Francone, Marco
Maranghi, Marianna
Arca, Marcello
author_sort D’Erasmo, Laura
collection PubMed
description BACKGROUND: Familial hypercholesterolemia (FH) may arise from deleterious monogenic variants in FH‐causing genes as well as from a polygenic cause. We evaluated the relationships between monogenic FH and polygenic hypercholesterolemia in influencing the long‐term response to therapy and the risk of atherosclerosis. METHODS AND RESULTS: A cohort of 370 patients with clinically diagnosed FH were screened for monogenic mutations and a low‐density lipoprotein‐rising genetic risk score >0.69 to identify polygenic cause. Medical records were reviewed to estimate the response to lipid‐lowering therapies and the occurrence of major atherosclerotic cardiovascular events during a median follow‐up of 31.0 months. A subgroup of patients (n=119) also underwent coronary computed tomographic angiography for the evaluation of coronary artery calcium score and severity of coronary stenosis as compared with 135 controls. Two hundred nine (56.5%) patients with hypercholesterolemia were classified as monogenic (FH/M+), 89 (24.1%) as polygenic, and 72 (19.5%) genetically undefined (FH/M−). The response to lipid‐lowering therapy was poorest in monogenic, whereas it was comparable in patients with polygenic hypercholesterolemia and genetically undetermined. Mean coronary artery calcium score and the prevalence of coronary artery calcium >100 units were significantly higher in FH/M+ as compared with both FH/M− and controls. Finally, after adjustments for confounders, we observed a 5‐fold higher risk of incident major atherosclerotic cardiovascular events in FH/M+ (hazard ratio, 4.8; 95% CI, 1.06–21.36; P (adj)=0.041). CONCLUSIONS: Monogenic cause of FH is associated with lower response to conventional cholesterol‐lowering therapies as well as with increased burden of coronary atherosclerosis and risk of atherosclerotic‐related events. Genetic testing for hypercholesterolemia is helpful in providing important prognostic information.
format Online
Article
Text
id pubmed-8200757
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82007572021-06-15 Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events D’Erasmo, Laura Minicocci, Ilenia Di Costanzo, Alessia Pigna, Giovanni Commodari, Daniela Ceci, Fabrizio Montali, Anna Brancato, Francesca Stanca, Ilaria Nicolucci, Antonio Ascione, Andrea Galea, Nicola Carbone, Iacopo Francone, Marco Maranghi, Marianna Arca, Marcello J Am Heart Assoc Original Research BACKGROUND: Familial hypercholesterolemia (FH) may arise from deleterious monogenic variants in FH‐causing genes as well as from a polygenic cause. We evaluated the relationships between monogenic FH and polygenic hypercholesterolemia in influencing the long‐term response to therapy and the risk of atherosclerosis. METHODS AND RESULTS: A cohort of 370 patients with clinically diagnosed FH were screened for monogenic mutations and a low‐density lipoprotein‐rising genetic risk score >0.69 to identify polygenic cause. Medical records were reviewed to estimate the response to lipid‐lowering therapies and the occurrence of major atherosclerotic cardiovascular events during a median follow‐up of 31.0 months. A subgroup of patients (n=119) also underwent coronary computed tomographic angiography for the evaluation of coronary artery calcium score and severity of coronary stenosis as compared with 135 controls. Two hundred nine (56.5%) patients with hypercholesterolemia were classified as monogenic (FH/M+), 89 (24.1%) as polygenic, and 72 (19.5%) genetically undefined (FH/M−). The response to lipid‐lowering therapy was poorest in monogenic, whereas it was comparable in patients with polygenic hypercholesterolemia and genetically undetermined. Mean coronary artery calcium score and the prevalence of coronary artery calcium >100 units were significantly higher in FH/M+ as compared with both FH/M− and controls. Finally, after adjustments for confounders, we observed a 5‐fold higher risk of incident major atherosclerotic cardiovascular events in FH/M+ (hazard ratio, 4.8; 95% CI, 1.06–21.36; P (adj)=0.041). CONCLUSIONS: Monogenic cause of FH is associated with lower response to conventional cholesterol‐lowering therapies as well as with increased burden of coronary atherosclerosis and risk of atherosclerotic‐related events. Genetic testing for hypercholesterolemia is helpful in providing important prognostic information. John Wiley and Sons Inc. 2021-04-23 /pmc/articles/PMC8200757/ /pubmed/33890476 http://dx.doi.org/10.1161/JAHA.120.018932 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
D’Erasmo, Laura
Minicocci, Ilenia
Di Costanzo, Alessia
Pigna, Giovanni
Commodari, Daniela
Ceci, Fabrizio
Montali, Anna
Brancato, Francesca
Stanca, Ilaria
Nicolucci, Antonio
Ascione, Andrea
Galea, Nicola
Carbone, Iacopo
Francone, Marco
Maranghi, Marianna
Arca, Marcello
Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
title Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
title_full Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
title_fullStr Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
title_full_unstemmed Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
title_short Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
title_sort clinical implications of monogenic versus polygenic hypercholesterolemia: long‐term response to treatment, coronary atherosclerosis burden, and cardiovascular events
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200757/
https://www.ncbi.nlm.nih.gov/pubmed/33890476
http://dx.doi.org/10.1161/JAHA.120.018932
work_keys_str_mv AT derasmolaura clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents
AT minicocciilenia clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents
AT dicostanzoalessia clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents
AT pignagiovanni clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents
AT commodaridaniela clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents
AT cecifabrizio clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents
AT montalianna clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents
AT brancatofrancesca clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents
AT stancailaria clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents
AT nicolucciantonio clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents
AT ascioneandrea clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents
AT galeanicola clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents
AT carboneiacopo clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents
AT franconemarco clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents
AT maranghimarianna clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents
AT arcamarcello clinicalimplicationsofmonogenicversuspolygenichypercholesterolemialongtermresponsetotreatmentcoronaryatherosclerosisburdenandcardiovascularevents